BNGO

Bionano Genomics Inc.

Price

$1.73

return (12m)

-3.35%

p/e

-0.62

p/bv

0.63

DIVIDEND YIELD

0.00%

BNGO price

Bionano Genomics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BNGO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

44.17%

3 months

50.43%

1 year

-3.35%

2 years

-92.89%

5 years

-99.95%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BNGO

Valuation

P/E

-0.62

Sector 1.14

Industry -1.74

P/BV

0.63

Sector 1.86

Industry 1.35

P/Revenue (PSR)

0.66

Sector 1.56

Industry 2.25

EV/EBITDA

-2.12

Sector -48.05

Industry -42.10

EV/EBIT

-1.42

Sector -27.46

Industry -45.23

P/EBITDA

-0.92

Sector -32.50

Industry -22.84

P/EBIT

-0.64

Sector -43.68

Industry -27.02

P/Total Assets

0.42

Sector 0.88

Industry 0.82

P/Net Current Assets

2.24

Sector -27.11

Industry -72.49

P/Working Capital

1.34

Sector 2.78

Industry -2.12

EPS

-2.79

Sector -0.70

Industry -1.11

BVPS

2.74

Sector 4.34

Industry 2.55

Efficiency

Gross Margin

47.51%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-57.64%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-86.37%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-100.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-100.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.17

Sector 0.13

Industry 0.06

Profitability

ROE

-101.76%

Sector -24.32%

Industry -33.33%

ROA

-67.58%

Sector -24.41%

Industry -45.73%

ROIC

-75.14%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.48

Sector 1.90

Industry 2.51

Net Debt / EBITDA

2.11

Sector -4.96

Industry -8.98

Net Debt / EBIT

1.41

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.31

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.66

Sector 0.46

Industry 0.52

Liabilities/Assets

0.34

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

10.91%

Sector -

Industry -

5Y Earnings CAGR

-14.99%

Sector -

Industry -

Fundamentals BNGO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BNGO Bionano Genomics Inc.	$1.73	-3.35%	0.00%	-0.62	0.63	-101.76%	-100.00%
TMO Thermo Fisher Scientific Inc.	$651.45	36.43%	0.28%	34.71	4.60	13.25%	15.07%
DHR Danaher Corporation	$211.81	10.60%	0.68%	37.21	2.83	7.61%	15.95%
WAT Waters Corporation	$421.63	40.14%	0.00%	250.55	2.74	1.09%	3.58%
IQV IQVIA Holdings Inc.	$266.42	42.30%	0.00%	32.18	7.04	21.87%	8.11%
SHC Sotera Health Company	$18.73	19.83%	0.00%	32.89	8.08	24.56%	13.44%
CGEN Compugen Ltd.	$2.49	87.22%	0.00%	8.46	2.62	31.01%	36.12%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
LLY Eli Lilly and Compay	$1,152.93	54.29%	0.59%	38.16	30.09	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$393.33	-10.35%	0.00%	44.01	7.60	17.26%	28.62%
SNY Sanofi	$42.48	-7.32%	4.17%	3.97	0.73	18.43%	14.25%
NVS Novartis AG	$140.37	16.41%	2.22%	20.89	6.35	30.39%	23.28%
ABT Abbott Laboratories	$102.61	-22.85%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.13	0.84%	3.11%	22.28	2.31	10.35%	14.02%
GSK GlaxoSmithKline PLC	$50.22	29.16%	3.54%	15.39	4.35	28.24%	14.54%
BSX Boston Scientific Corp.	$43.34	-55.70%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$86.42	-29.33%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$224.99	-16.77%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$511.65	-22.02%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$427.71	7.02%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$317.36	190.86%	0.00%	75.62	5.36	7.09%	11.19%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BNGO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Bionano Genomics

Bionano Genomics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

19 years

Founded: 2007

2018

Time since IPO - 8 years

147

Employees

Bionano Genomics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $19.92 million, with shareholders equity totaling $31.61 million.

The company employs approximately 147 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Bionano Genomics Inc. reported $30.18 million in revenue, generating net income of $-32.16 million.

Key financial metrics include a P/E ratio of -0.62, a price-to-book (P/B) ratio of 0.63, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BNGO.

Market cap

$19.92 million

Net worth

$31.61 million

$31,606,000.00

Assets

$47.59 million

$47,591,000.00

Total Shares Outstanding

11.55 million

11,546,000

Average Daily Trading Volume

$1.04 million

$1,037,368.00

Sector

Health

Industry

Life Science Tools and Services

BNGO

BNGO revenue and profits

Financial Results BNGO

DRAG THE FRAME TO SEE MORE DATA

BNGO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.84 22,33% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.28 --3,05% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.11 104,94% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$386.22 55,41% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.48 --7,32% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,152.93 54,29% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$427.71 7,02% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$140.37 16,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35